Page 236 - 北京京煤集团总医院第十届·2022学术年会论文集
P. 236

北京京煤集团总医院                                              第十届·2022 学术年会论文集


                                    Helveticoside                              8.70E-07

                                      Ouabain                                  9.12E-07

                                     Bisacodyl                                 2.32E-06

                   Table 4 The top 10 drugs with the greatest potential of affecting the expression of the common

                   DEGs between COVID-19 and asthma

                   4.  Discussion

                       Numerous studies have reported that asthma patients may have an increased risk of SARS-
                   CoV-2  infection  and  disease  severity,  and  SARS-CoV-2  asthma  patients  have  a  wide  range  of

                   clinical manifestations [22, 23]. However, the underlying mechanisms of COVID-19 and asthma

                   remain unclear. Thus, in this study, we aimed to identify potential biomarkers for COVID-19 and

                   asthma. A  total  of  135  overlapped  DEGs  were  obtained  by  determining  the  DEG  intersection

                   between the GSE147507 and GSE143303 datasets, and these overlapped DEGs were significantly

                   enriched in eight KEGG pathways. The PPI network revealed that  HSPA8, SRSF1, NDUFAB1,

                   PTEN, CCT8, HIST1H2BK, HIST2H2BE, DLAT, EIF3G, and WAC, with high scores, were the hub

                   genes. In addition, 65 TFs and 369 miRNAs were found to target overlapping DEGs. Finally, the

                   target drug and related diseases of the overlapped DEGs were predicted.

                       Based on GSE147507 and GSE143303 datasets, 135 overlapping DEGs were identified. These

                   135  genes  may  serve  as  potential  markers  of  COVID-19  and  asthma.  In  addition,  enrichment

                   analysis was performed to analyze the mechanism of overlapping DEGs in COVID-19 and asthma.

                   The GOs results showed that the overlapping DEGs were enriched in regulating DNA-templated
                   transcription,  initiation,  clathrin-sculpted  gamma-aminobutyric  acid  transport  vesicle,  and  DNA

                   binding. KEGG pathways were enriched in Parkinson’s disease, diabetic cardiomyopathy, and the

                   citrate cycle (TCA cycle). Numerous studies have found that SARS-CoV-2 has direct or indirect

                   effects on Parkinson’s disease [24–26], and anti-Parkinson disease drugs may have protective or

                   harmful effects on severe COVID-19 prevention [27, 28]. Fasano et al. showed that frailty caused

                   by advanced Parkinson’s disease increases the risk of death during COVID-19 [29]. Cheng et al.

                   revealed that patients with asthma have a higher risk of Parkinson’s disease later in life [30]. SARS-

                   CoV-2 infection can cause cardiac complications [31]. Citrate is a vital substrate in cellular energy

                   metabolism, and evidence has shown that citrate is involved in inflammation, neurological disorders,




                                                          - 231 -
   231   232   233   234   235   236   237   238   239   240   241